Arcutis Biotherapeutics Reports Significant Revenue Growth in 2024

Westlake Village, Sunday, 12 January 2025.
Arcutis Biotherapeutics announces a 449% increase in 2024 product revenue, reaching $160 million, driven by strong demand for ZORYVE. Full financial results to be released February 25, 2025.